Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 206
Filter
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 262: 120091, 2021 Dec 05.
Article in English | MEDLINE | ID: mdl-34175760

ABSTRACT

Spectroscopic methods provide information on the spatial localization of biochemical components based on the analysis of vibrational spectra. Raman spectroscopy and Raman imaging can be used to analyze various types of human brain tumors and breast cancers. The objective of this study is to evaluate the Raman biomarkers to distinguish tumor types by Raman spectroscopy and Raman imaging. We have demonstrated that bands characteristic for carotenoids (1156 cm-1, 1520 cm-1), proteins (1004 cm-1), fatty acids (1444 cm-1, 1655 cm-1) and cytochrome (1585 cm-1) can be used as universal biomarkers to assess aggressiveness of human brain tumors. The sensitivity and specificity obtained from PLS-DA have been over 73%. Only for gliosarcoma WHO IV the specificity is lower and takes equal 50%. The presented results confirm clinical potential of Raman spectroscopy in oncological diagnostics.


Subject(s)
Brain Neoplasms , Breast Neoplasms , Brain Neoplasms/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Diagnostic Imaging , Female , Humans , Spectrum Analysis, Raman , Vibration
2.
Adv Exp Med Biol ; 955: 47-50, 2017.
Article in English | MEDLINE | ID: mdl-28039663

ABSTRACT

Bordetella pertussis is a gram-negative aerobic coccobacillus causing contagious respiratory tract disease called whooping cough. The virulence factors consist of pertussis toxin, filamentous hemagglutinin, fimbriae, lipooligosaccharide, and adenylate cyclase toxin. The disease causes a worldwide threat to public health despite a high vaccination coverage. The course of whooping cough in adults is frequently atypical, causing difficulty in diagnosis. In this report we present five patients hospitalized with Bordetella pertussis infection manifesting atypical and severe symptoms. The diagnosis was based on serological tests: serum concentration of specific antibodies against pertussis toxin and sputum cultures. We observed a wide spectrum of symptoms, from benign (sinus pain - 80 %, headaches - 20 %), through moderate (hemoptysis - 40 %; chest pain 60 %) to severe symptoms (cardiac arrhythmia - 40 %; syncope - 60 %). Bordetella pertussis infection can cause life-threatening complications and exacerbation of concomitant chronic diseases. Most vaccination programs cover only the first few months of life. Booster doses should be considered in adults, especially those immunocompromised or with pulmonary complications, but also in healthcare workers who are exposed to the contagion and also may spread the infection.


Subject(s)
Bordetella pertussis/isolation & purification , Whooping Cough , Adult , Age of Onset , Aged , Anti-Bacterial Agents/therapeutic use , Antibodies, Bacterial/blood , Bacteriological Techniques , Bordetella pertussis/drug effects , Bordetella pertussis/immunology , Female , Hospitalization , Humans , Immunization Schedule , Male , Middle Aged , Pertussis Vaccine/administration & dosage , Serologic Tests , Severity of Illness Index , Sputum/microbiology , Treatment Outcome , Whooping Cough/diagnosis , Whooping Cough/drug therapy , Whooping Cough/immunology , Whooping Cough/microbiology
3.
Adv Exp Med Biol ; 955: 59-63, 2017.
Article in English | MEDLINE | ID: mdl-27815923

ABSTRACT

One of the most common gastrointestinal infection after the antibiotic treatment of community or nosocomial pneumonia is caused by the anaerobic spore Clostridium difficile (C. difficile). The aim of this study was to retrospectively assess mortality due to C. difficile infection (CDI) in patients treated for pneumonia. We identified 94 cases of post-pneumonia CDI out of the 217 patients with CDI. The mortality issue was addressed by creating a mortality risk models using logistic regression and multivariate fractional polynomial analysis. The patients' demographics, clinical features, and laboratory results were taken into consideration. To estimate the influence of the preceding respiratory infection, a pneumonia severity scale was included in the analysis. The analysis showed two statistically significant and clinically relevant mortality models. The model with the highest prognostic strength entailed age, leukocyte count, serum creatinine and urea concentration, hematocrit, coexisting neoplasia or chronic obstructive pulmonary disease. In conclusion, we report on two prognostic models, based on clinically relevant factors, which can be of help in predicting mortality risk in C. difficile infection, secondary to the antibiotic treatment of pneumonia. These models could be useful in preventive tailoring of individual therapy.


Subject(s)
Anti-Bacterial Agents/adverse effects , Clostridioides difficile/isolation & purification , Enterocolitis, Pseudomembranous/microbiology , Enterocolitis, Pseudomembranous/mortality , Pneumonia/drug therapy , Enterocolitis, Pseudomembranous/diagnosis , Humans , Logistic Models , Multivariate Analysis , Odds Ratio , Pneumonia/diagnosis , Pneumonia/microbiology , Pneumonia/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Time Factors
4.
Adv Exp Med Biol ; 2016 Dec 14.
Article in English | MEDLINE | ID: mdl-27966110

ABSTRACT

Clostridium difficile infection (CDI) is one of the most common gastrointestinal complication after antimicrobial treatment. It is estimated that CDI after pneumonia treatment is connected with a higher mortality than other causes of hospitalization. The aim of the study was to assess the relationship between the kind of antibiotic used for pneumonia treatment and mortality from post-pneumonia CDI. We addressed the issue by examining retrospectively the records of 217 patients who met the diagnostic criteria of CDI. Ninety four of those patients (43.3 %) came down with CDI infection after pneumonia treatment. Fifty of the 94 patients went through severe or severe and complicated CDI. The distribution of antecedent antibiotic treatment of pneumonia in these 50 patients was as follows: ceftriaxone in 14 (28 %) cases, amoxicillin with clavulanate in 9 (18 %), ciprofloxacin in 8 (16.0 %), clarithromycin in 7 (14 %), and cefuroxime and imipenem in 6 (12 %) each. The findings revealed a borderline enhancement in the proportion of deaths due to CDI in the ceftriaxone group compared with the ciprofloxacin, cefuroxime, and imipenem groups. The corollary is that ceftriaxone should be shunned in pneumonia treatment. The study demonstrates an association between the use of a specific antibiotic for pneumonia treatment and post-pneumonia mortality in patients who developed CDI.

5.
Public Health ; 141: 178-184, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27931996

ABSTRACT

OBJECTIVES: We investigate trends in the prevalence of cigarette smoking among adults at all ages in two time points 9 years apart in two neighbouring rural populations and examine social and respiratory health determinants of quitting smoking. STUDY DESIGN: Repeated cross-sectional study. METHODS: Two cross-sectional surveys were conducted in the same rural area of lower Silesia in Poland in 2003 and 2012. A total of 1328 (91% of adult eligible individuals) in 2003 and 1449 (92% of eligible) in 2012 adult inhabitants were surveyed, 908 people (560 villagers and 348 town inhabitants) participated in both surveys. Participants completed a questionnaire on smoking behaviour, education level and respiratory diseases. RESULTS: Current smoking was higher in the villages than the town, among men than women and those with a middle level of education. The prevalence of current smokers decreased over time, although this decline was much more pronounced in the town than in the villages (30.2% vs 23% and 35.5% vs 33.7%, respectively). Men were more likely to stop smoking than women both in villages and in town. The prevalence of current smokers among village women even increased between the two surveys from 27.6% to 29.3%. Respiratory diseases did not influence quitting smoking. CONCLUSIONS: The degree of decreasing trend in smoking prevalence varied considerably within neighbouring populations. It was mainly seen in the town and among younger people. Men and those better educated were more willing to quit smoking. The discrepancies between two close rural populations indicates the need for an individual approach when designing programs of tobacco control.


Subject(s)
Rural Population/statistics & numerical data , Smoking Cessation/statistics & numerical data , Smoking/epidemiology , Social Determinants of Health , Adolescent , Adult , Age Distribution , Cross-Sectional Studies , Educational Status , Female , Health Surveys , Humans , Male , Middle Aged , Poland/epidemiology , Prevalence , Residence Characteristics/statistics & numerical data , Respiratory Tract Diseases/epidemiology , Sex Distribution , Smoking/psychology , Young Adult
6.
Adv Exp Med Biol ; 952: 59-64, 2016.
Article in English | MEDLINE | ID: mdl-27620311

ABSTRACT

Clostridium difficile infection (CDI) is one of the most common gastrointestinal complication after antimicrobial treatment. It is estimated that CDI after pneumonia treatment is connected with a higher mortality than other causes of hospitalization. The aim of the study was to assess the relationship between the kind of antibiotic used for pneumonia treatment and mortality from post-pneumonia CDI. We addressed the issue by examining retrospectively the records of 217 patients who met the diagnostic criteria of CDI. Ninety four of those patients (43.3 %) came down with CDI infection after pneumonia treatment. Fifty of the 94 patients went through severe or severe and complicated CDI. The distribution of antecedent antibiotic treatment of pneumonia in these 50 patients was as follows: ceftriaxone in 14 (28 %) cases, amoxicillin with clavulanate in 9 (18 %), ciprofloxacin in 8 (16.0 %), clarithromycin in 7 (14 %), and cefuroxime and imipenem in 6 (12 %) each. The findings revealed a borderline enhancement in the proportion of deaths due to CDI in the ceftriaxone group compared with the ciprofloxacin, cefuroxime, and imipenem groups. The corollary is that ceftriaxone should be shunned in pneumonia treatment. The study demonstrates an association between the use of a specific antibiotic for pneumonia treatment and post-pneumonia mortality in patients who developed CDI.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clostridioides difficile/drug effects , Clostridium Infections/drug therapy , Cross Infection/drug therapy , Pneumonia/drug therapy , Aged , Aged, 80 and over , Amoxicillin/therapeutic use , Ceftriaxone/therapeutic use , Cefuroxime/therapeutic use , Ciprofloxacin/therapeutic use , Clarithromycin/therapeutic use , Clavulanic Acid/therapeutic use , Clostridioides difficile/physiology , Clostridium Infections/complications , Clostridium Infections/microbiology , Cross Infection/complications , Cross Infection/microbiology , Female , Hospitalization/statistics & numerical data , Host-Pathogen Interactions/drug effects , Humans , Imipenem/therapeutic use , Male , Pneumonia/complications , Retrospective Studies , Treatment Outcome
7.
Pol J Vet Sci ; 19(2): 253-9, 2016.
Article in English | MEDLINE | ID: mdl-27487498

ABSTRACT

The extracellular matrix (ECM) is important in the regulation of myogenesis. We hypothesized that tumor necrosis factor-α (TNF-α) modifies ECM during differentiation of mouse C2C12 myoblasts. Exogenous TNF-α (1 ng/ml) stimulated myoblast fusion on the 3rd day (by 160% vs control) but not on the 5th day of myogenesis. The level of integrin α5 was significantly augmented by TNF-α during 5 day-differentiation; however, integrin ß1 was higher than control only on the 3rd day of cytokine treatment. Both the abundance of integrin α5 bound to actin and the level of integrin ß1 complexed with integrin α5 increased in the presence of TNF-α, especially on the 3rd day of differentiation. Similarly, the stimulatory effects of TNF-α on integrin α3, metalloprotease ADAM12 and kinases related to integrins, FAK and ILK, were limited to the 3rd day of differentiation. We concluded that TNF-α-induced changes in ECM components in differentiating myogenic cells, i.e. i) increased expression of integrin α5, ß1, α3, and metalloprotease ADAM12, ii) enhanced formation of α5ß1 integrin receptors and interaction of integrin α5-cytoskeleton, and iii) increased expression of kinases associated with integrin signaling, FAK and ILK, were temporarily associated with the onset of myocyte fusion.


Subject(s)
ADAM12 Protein/metabolism , Integrins/metabolism , Myoblasts/drug effects , Signal Transduction/drug effects , Tumor Necrosis Factor-alpha/pharmacology , ADAM12 Protein/genetics , Animals , Cell Line , Gene Expression Regulation/drug effects , Integrins/genetics , Mice , Myoblasts/metabolism , Tumor Necrosis Factor-alpha/administration & dosage
8.
Cell Biol Toxicol ; 32(3): 185-98, 2016 06.
Article in English | MEDLINE | ID: mdl-27114085

ABSTRACT

High-fat diet, exposure to saturated fatty acids, or the presence of adipocytes in myoblast microenvironment affects skeletal muscle growth and function. The aim of the present study was to investigate the effect of palmitate supplementation on transcriptomic profile of mouse C2C12 myoblasts. Global gene expression was evaluated using whole mouse genome oligonucleotide microarrays, and the results were validated through qPCR. A total of 4047 genes were identified as differentially expressed, including 3492 downregulated and 555 upregulated genes, during a 48-h exposure to palmitate (0.1 mmol/l). Functional classification showed the involvement of these genes in several processes which regulate cell growth. In conclusion, the addition of palmitate modifies the expression of genes associated with (1) myoblast responsiveness to hormones and growth factors, (2) cytokine and growth factor expression, and (3) regulation of cell-cell and cell-matrix communication. Such alterations can affect myoblast growth and differentiation; however, further studies in this field are required.


Subject(s)
Myoblasts/drug effects , Myoblasts/physiology , Palmitic Acid/pharmacology , Transcriptome/drug effects , Animals , Cell Cycle , Cell Differentiation/drug effects , Cell Line , Cell Proliferation/drug effects , Gene Expression Regulation/drug effects , Mice , Muscle Development/drug effects , Muscle Development/physiology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Myoblasts/metabolism , Oligonucleotide Array Sequence Analysis
9.
Adv Exp Med Biol ; 884: 13-9, 2016.
Article in English | MEDLINE | ID: mdl-26542595

ABSTRACT

Granulomatosis with polyangiitis (GPA), a disease capable of affecting any organ, most often acts upon the upper respiratory tract. Diagnostic imaging is primarily represented by computed tomography (CT) of paranasal sinuses. The aim of this study was to define the characteristic changes in paranasal CT in patients with GPA and to evaluate diagnostic usefulness of the Lund-Mackey scoring system (L-M System). The study encompassed 43 patients with GPA of the mean age of 47.7 ± 12.8 years who were treated topically with mupirocin. We found that inflammation occurred mainly in the maxillary sinuses (72%). The mean L-M score was 5.8 ± 6.1. The right maxillary sinus had the highest percentage (12.6%) of score hits of 1, i.e., partial opacification and the left ostiomeatal complex had the highest percentage (7.6%) of score of 2, i.e., complete opacification or obstruction. The following changes were the most characteristic for GPA: sinus mucosal thickening, widespread bone damage, and osteogenesis. We conclude that the long-term topical mupirocin treatment of GPA may inhibit nasal bone damage, but also may led to permanent rhinological changes of the rhinosinusitis type. The Lund-Mackey staging system is a useful diagnostic imaging option in GPA patients.


Subject(s)
Granulomatosis with Polyangiitis/diagnostic imaging , Multidetector Computed Tomography , Paranasal Sinuses/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Administration, Topical , Adult , Anti-Bacterial Agents/administration & dosage , Female , Granulomatosis with Polyangiitis/drug therapy , Humans , Male , Maxillary Sinus/diagnostic imaging , Middle Aged , Mupirocin/administration & dosage , Nasal Bone/diagnostic imaging , Nasal Mucosa/diagnostic imaging , Osteogenesis , Paranasal Sinuses/drug effects , Predictive Value of Tests , Treatment Outcome
10.
Adv Exp Med Biol ; 878: 1-7, 2016.
Article in English | MEDLINE | ID: mdl-26269029

ABSTRACT

Granulomatosis with Polyangiitis (GPA) is a rare disease of unknown origin. It may damage all organs and systems, even olfactory and taste sense. The aim of the study was to determine the sense of smell in patients with GPA and to identify factors related to disease course, activity, and duration, which may be associated with olfactory dysfunction. The comparison of olfactory function screening scores with Sniffin' Sticks standardized norms showed that 74% of the investigated patients had olfactory dysfunction. The olfactory performance was diminished in all parts of Sniffin' Sticks test: threshold scores 4.4 vs. 7.1 (p = 0.007); odor discrimination 9.0 vs. 11.9 (p = 0.008); and olfactory identification 9.8 vs. 12.2 (p = 0.011) in the GPA patients vs. control subjects, respectively. Scores acquired during all three parts of the test were combined to assess the TDI-score. The median TDI-score in the GPA group (27.5) was significantly lower than that in the control group (32.0) (p = 0.002). Active nasal and paranasal sinus inflammation in GPA leads to olfactory dysfunction, the patients are often unaware of. The dysfunction is permanent and does not abates along with decreasing intensity of the inflammatory process. GPA therapy should include recommendations on nutrition, personal hygiene, and food poisoning prevention.


Subject(s)
Granulomatosis with Polyangiitis/diagnosis , Olfaction Disorders/diagnosis , Paranasal Sinus Diseases/diagnosis , Adolescent , Adult , Aged , Case-Control Studies , Female , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/epidemiology , Humans , Male , Middle Aged , Olfaction Disorders/epidemiology , Paranasal Sinus Diseases/epidemiology , Prevalence , Sensory Thresholds
11.
Allergy ; 70(6): 661-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25832475

ABSTRACT

BACKGROUND: We examined the associations of family size and birth order with atopy prevalence in rural Poland at two time periods. METHODS: Two cross-sectional surveys were conducted in the same villages and a small town of lower Silesia at an interval of 9 years. In 2003, 1700 (88% of eligible individuals), and in 2012, 1730 (86%) inhabitants aged 5 years or more completed a questionnaire and had a skin prick test for atopy. RESULTS: There was an inverse association between family size and atopy in the village population in 2003; the prevalence of atopy was the highest for those with no siblings (15.2%) and decreased to 5.4% for those with three and more siblings (OR = 0.22; 0.07-0.66). In contrast, there was little or no such protective effect in the town population where the prevalence of atopy was much higher (7.3% in the villages, 20.0% in the town). Nine years later, the prevalence of atopy had increased in the village to be similar to that in the town (19.6% and 19.9% respectively), and the protective effects of family size and birth order in the villages were much weaker (OR = 0.64; 95% CI 0.33-1.27 for three or more siblings). Both protective effects were strongest among children. CONCLUSIONS: The protective effects of family size and birth order on atopy were much stronger in children than in adults and among those living in a village. They largely disappeared with the steep increase in atopy prevalence at all ages; this followed environmental changes on the village farms.


Subject(s)
Birth Order , Family Characteristics , Hypersensitivity, Immediate/epidemiology , Rural Population , Siblings , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Agriculture , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Poland/epidemiology , Prevalence , Protective Factors , Skin Tests , Young Adult
12.
J Endocrinol Invest ; 37(3): 233-45, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24615360

ABSTRACT

BACKGROUND: Myogenesis is susceptible to the availability of nutrients and humoral factors and suboptimal fetal environments affect the number of myofibers and muscle mass. AIM: We examined the mechanisms regulating cell cycle progression and arrest in skeletal myoblasts. MATERIALS AND METHODS: Mouse C2C12 myoblasts were subjected to proliferation or induction of differentiation in the presence of high glucose and high insulin (HGHI glucose 15 mmol/l, insulin 50 nmol/l), and these effects were compared with the influence of anabolic factor for skeletal muscle, insulin-like growth factor-I (IGF-I 30 nmol/l). RESULTS: High glucose and high insulin, similarly to IGF-I, increased the intracellular level of cyclin A, cyclin B1 and cyclin D1 during myoblast proliferation. In HGHI-treated myoblasts, these cyclins were localized mostly in the nuclei, and the level of cdk4-bound cyclin D1 was augmented. HGHI significantly stimulated the expression of cyclin D3, total level of p21 and cdk-bound fraction of p21 in differentiating cells. The cellular level of MyoD was augmented by HGHI both in proliferating and differentiating myogenic cells. CONCLUSIONS: High glucose and insulin modify the mechanisms controlling cell cycle progression and the onset of myogenesis by: (1) increase of cyclin A, cyclin B1 and cyclin D1 in myoblast nuclei, and stimulation of cyclin D1-cdk4 binding; (2) increase in cyclin D3 and MyoD levels, and the p21-cdk4 complexes after induction of differentiation. Hyperglycemia/hyperinsulinemia during fetal or postnatal life could exert effects similar to IGF-I and can be, therefore, favourable for skeletal muscle growth and regeneration.


Subject(s)
Cell Cycle/physiology , Glucose/pharmacology , Insulin-Like Growth Factor I/pharmacology , Insulin/pharmacology , Myoblasts/cytology , Myoblasts/drug effects , Animals , Blotting, Western , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Fluorescent Antibody Technique , Hypoglycemic Agents/pharmacology , Immunoprecipitation , Mice , Myoblasts/metabolism , Sweetening Agents/pharmacology
13.
Pol J Vet Sci ; 16(2): 255-64, 2013.
Article in English | MEDLINE | ID: mdl-23971193

ABSTRACT

The purpose of the study was to examine the mechanisms important for early myogenesis in mouse C2C12 myogenic cells exposed to interleukin-1beta. Cyclin A and cyclin B1 were increased by interleukin-1beta (1 ng/ml), but the level of cyclin D1 and total DNA content was unaffected. Fusion index and the rate of protein synthesis was increased in the presence of IL-1beta, but these effects were limited to 3-day-treatment. IL-1beta increased the level of MyoD, myogenin and MHC on the 3rd day of differentiation, without altering the content of the active form of myostatin, as well as it augmented the level of fibronectin, integrin beta1 and full length 100 kDa form of ADAM12. IL-1beta caused a decrease in IGFBP-4 and IGFBP-6 levels and a marked increase in IGFBP-5. The phosphorylation of PKB and ERK1/2 and the cellular content of p38 were elevated by IL-1beta. We conclude that the myogenic effect of IL-1beta was limited to the onset of myoblast fusion and was associated with: i) increase in the level of myogenic transcription factors i.e. MyoD and myogenin expression, ii) modification of extracellular matrix assembly and signaling, manifested by an increase in fibronectin, integrin-beta1 and ADAM12 content, iii) drop in IGFBP-4 and IGFBP-6, and an increase in IGFBP-5, that could alter the local IGF-1 bioavailability, and iv) increase in phosphorylation of PKB and ERK1/2, and the expression of p38 kinase, leading to activation of intracellular pathways essential for myogenic differentiation.


Subject(s)
Extracellular Matrix/metabolism , Insulin-Like Growth Factor Binding Proteins/metabolism , Interleukin-1beta/pharmacology , Muscle Development/drug effects , Myoblasts/drug effects , Myogenic Regulatory Factors/metabolism , Animals , Cell Differentiation/drug effects , Cell Line , Cell Proliferation/drug effects , Extracellular Matrix/chemistry , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Insulin-Like Growth Factor Binding Proteins/genetics , Mice , Muscle Development/physiology , Myoblasts/cytology , Myogenic Regulatory Factors/genetics , Protein Kinases/genetics , Protein Kinases/metabolism
17.
J Eur Acad Dermatol Venereol ; 19(4): 462-5, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15987294

ABSTRACT

We present an unusual tumorous variety of scleromyxedema mimicking facies leonina in lymphoma. In spite of pronounced and widespread cutaneous changes, hypergammaglobulinaemia and paraproteinaemia, the general condition of the patient was satisfactory, there was no internal involvement and no symptoms of any malignancy. Initially, melphalan and corticosteroids were applied but were not effective. High-dose intravenous immunoglobulin (IVIG) therapy had dramatic effect, and after five 5-day monthly courses the tumours almost regressed and the skin became less hard. After a further five courses in the following year there was complete clearance, which was sustained without any therapy for 1 year (until now). IVIG appears to be the therapy of choice for scleromyxedema. We stress, however, that at the start of therapy, IVIG applications should be supplemented with small doses of melphalan and/or corticosteroids.


Subject(s)
Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Immunoglobulins, Intravenous/administration & dosage , Myxedema/diagnosis , Myxedema/drug therapy , Diagnosis, Differential , Facial Dermatoses/pathology , Female , Humans , Middle Aged , Myxedema/pathology
18.
Br J Surg ; 90(12): 1516-21, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14648730

ABSTRACT

BACKGROUND: This study evaluated a single-centre experience with endovascular repair of traumatic arteriovenous fistula in the cervicothoracic region. METHODS: Endovascular repair of 27 traumatic cervicothoracic arteriovenous fistulas was attempted between August 1998 and December 2001. Patients with active bleeding or end-organ ischaemia were excluded. Follow-up was accomplished with clinical, duplex Doppler and arteriographic evaluation after 1 month and then every 3 months. RESULTS: Twelve patients with a major vessel injury were treated by stent-graft placement. Vessels involved were the subclavian (eight), common carotid (three) and internal carotid (one) arteries. Subclavian artery side branches were embolized in three of the eight patients. Four patients developed early type 4 endoleaks but all resolved. Treatment with stent-grafts was ultimately successful in all 12 patients. Three patients were lost to follow-up. During mean follow-up of 21 (range 3-36) months, one of the remaining patients developed a graft stenosis. Fifteen patients with minor vessel injuries were treated with arterial embolization. Vessels embolized were subclavian artery branches (four), external carotid artery and branches (seven) and vertebral arteries (four). Successful embolization was accomplished in ten of 15 patients. CONCLUSION: Endovascular therapy is a promising alternative to surgery for selected patients with cervicothoracic arteriovenous fistula.


Subject(s)
Arteriovenous Fistula/therapy , Carotid Artery Injuries/therapy , Adolescent , Adult , Arteries/injuries , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/methods , Carotid Artery, Common , Carotid Artery, Internal , Child , Embolization, Therapeutic/methods , Female , Follow-Up Studies , Humans , Male , Neck Injuries/etiology , Neck Injuries/therapy , Stents , Treatment Outcome , Wounds, Gunshot/therapy , Wounds, Stab/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...